BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15526164)

  • 1. Integration target site selection for retroviruses and transposable elements.
    Wu X; Burgess SM
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2588-96. PubMed ID: 15526164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration site selection by retroviruses and transposable elements in eukaryotes.
    Sultana T; Zamborlini A; Cristofari G; Lesage P
    Nat Rev Genet; 2017 May; 18(5):292-308. PubMed ID: 28286338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.
    Derse D; Crise B; Li Y; Princler G; Lum N; Stewart C; McGrath CF; Hughes SH; Munroe DJ; Wu X
    J Virol; 2007 Jun; 81(12):6731-41. PubMed ID: 17409138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internal transcriptional regulatory elements in HIV-1 and other retroviruses.
    Verdin E; Van Lint C
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):365-9. PubMed ID: 7580829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of retroviral integration and mutagenesis.
    Cavazza A; Moiani A; Mavilio F
    Hum Gene Ther; 2013 Feb; 24(2):119-31. PubMed ID: 23330935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors.
    Sokol M; Wabl M; Ruiz IR; Pedersen FS
    Retrovirology; 2014 May; 11():36. PubMed ID: 24886479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration site selection by retroviral vectors: molecular mechanism and clinical consequences.
    Daniel R; Smith JA
    Hum Gene Ther; 2008 Jun; 19(6):557-68. PubMed ID: 18533894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Analysis of Transposon and Retroviral Insertions Reveals Preferential Integrations in Regions of DNA Flexibility.
    Vrljicak P; Tao S; Varshney GK; Quach HN; Joshi A; LaFave MC; Burgess SM; Sampath K
    G3 (Bethesda); 2016 Apr; 6(4):805-17. PubMed ID: 26818075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration site selection by retroviruses.
    Cereseto A; Giacca M
    AIDS Rev; 2004; 6(1):13-21. PubMed ID: 15168737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selection.
    Demeulemeester J; De Rijck J; Gijsbers R; Debyser Z
    Bioessays; 2015 Nov; 37(11):1202-14. PubMed ID: 26293289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription start regions in the human genome are favored targets for MLV integration.
    Wu X; Li Y; Crise B; Burgess SM
    Science; 2003 Jun; 300(5626):1749-51. PubMed ID: 12805549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of retroviral vectors.
    Gabriel R; Schmidt M; von Kalle C
    Curr Opin Immunol; 2012 Oct; 24(5):592-7. PubMed ID: 22981243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV-Based Vectors and for a Cure for HIV-1 Infection.
    Pellaers E; Bhat A; Christ F; Debyser Z
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site.
    Dorssers LC; van Agthoven T; Dekker A; van Agthoven TL; Kok EM
    Mol Endocrinol; 1993 Jul; 7(7):870-8. PubMed ID: 8413311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral DNA Transposition: Themes and Variations.
    Skala AM
    Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix attachment regions as targets for retroviral integration.
    Johnson CN; Levy LS
    Virol J; 2005 Aug; 2():68. PubMed ID: 16111492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile sites are preferential targets for integrations of MLV vectors in gene therapy.
    Bester AC; Schwartz M; Schmidt M; Garrigue A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Ben-Porat N; Von Kalle C; Fischer A; Kerem B
    Gene Ther; 2006 Jul; 13(13):1057-9. PubMed ID: 16511518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse transcription in the eukaryotic genome: retroviruses, pararetroviruses, retrotransposons, and retrotranscripts.
    Temin HM
    Mol Biol Evol; 1985 Nov; 2(6):455-68. PubMed ID: 2835576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration site preferences of endogenous retroviruses.
    Taruscio D; Manuelidis L
    Chromosoma; 1991 Dec; 101(3):141-56. PubMed ID: 1790730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral DNA integration: viral and cellular determinants of target-site selection.
    Lewinski MK; Yamashita M; Emerman M; Ciuffi A; Marshall H; Crawford G; Collins F; Shinn P; Leipzig J; Hannenhalli S; Berry CC; Ecker JR; Bushman FD
    PLoS Pathog; 2006 Jun; 2(6):e60. PubMed ID: 16789841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.